Compare CVS Health Corp (CVS) vs Direxion Daily FTSE China Bull 3x Shares (YINN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Direxion Daily FTSE China Bull 3x Shares — how do they compare? CVS Health Corp trades at $86.62 (market cap $112.49B), while Direxion Daily FTSE China Bull 3x Shares trades at $24.54 (market cap $574.76M). The key difference: CVS Health Corp is far larger — about 195.7× Direxion Daily FTSE China Bull 3x Shares's market cap, and CVS Health Corp pays a 3.02% dividend while Direxion Daily FTSE China Bull 3x Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Direxion Daily FTSE China Bull 3x Shares for 25 Days on average.
| CVS | YINN | |
|---|---|---|
Market Cap | $112.49B | $574.76M |
Volume | 8,467,392 | 1,122,984 |
Sector | Health | Leveraged / Inverse |
52-Week High | $110.60 | $52.69 |
52-Week Low | $70.08 | $21.45 |
Typical Hold Time | 83 Days | 25 Days |
Enterprise Value | $174.83B | — |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
YINN is trading at $23.56, down 2.97% with a bearish technical outlook. Moving averages signal strong selling pressure while oscillators remain neutral. The stock faces resistance at $24 with support at $23. Recent news highlights China's economic policies affecting Asian markets, though YINN's specific financial metrics are unavailable in the current dataset.
The technical setup suggests continued near-term pressure with key resistance at $24. Investment opportunities depend on China's economic recovery trajectory, while risks include regulatory controls and regional market volatility. The absence of current fundamental data requires careful due diligence before considering position entry.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Direxion Daily FTSE China Bull 3x Shares
YINN is a leveraged ETF that seeks daily investment results, before fees and expenses, of 300% (3x) of the daily performance of the FTSE China 50 Index. It is a tactical instrument designed for sophisticated traders seeking to magnify short-term bullish views on large-cap Chinese equities, primarily those trading on the Hong Kong Stock Exchange.
Read more on YINN →
